Physician

Christine Isabel Clavell, MD

According to 2025 Medicare claims, Christine Clavell, MD (NPI: 1124382056) practices ophthalmology in the Santa Fe, NM market, with the plurality of this provider's patient population coming from Santa Fe, NM. This provider's primary affiliated billing organization is EYE ASSOCIATES OF NEW MEXICO LTD (NPI: 1104868520; TIN: 85-0246856) and primary practice location at 87505-6303. Clavell is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Clavell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 243 traditional Medicare patients, billed 3,624 HCPCS/CPT codes, and received $247,743 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 350 prescription claims across 137 beneficiaries totaling $12,921 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 3 records totaling $163. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $32,572 to $247,743. In contrast, Part D prescription costs have risen steadily, from $2,937 to $12,921. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$638K$1.3M2016 Medicare payment: $32,572 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $145,412 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $764,026 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,275,004 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,026,880 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $880,219 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $343,357 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $16,258 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $247,743 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016269588$32,572
20175321,626$145,412
20182453,764$764,026
20193354,532$1,275,004
20202593,661$1,026,880
20212943,285$880,219
20222411,421$343,357
202368109$16,258
20242433,624$247,743

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$10K$21K2015 Drug cost: $2,937 (USD; Tot_Drug_Cst)2016 Drug cost: $1,154 (USD; Tot_Drug_Cst)2017 Drug cost: $3,165 (USD; Tot_Drug_Cst)2018 Drug cost: $12,157 (USD; Tot_Drug_Cst)2019 Drug cost: $15,577 (USD; Tot_Drug_Cst)2020 Drug cost: $20,646 (USD; Tot_Drug_Cst)2021 Drug cost: $12,958 (USD; Tot_Drug_Cst)2022 Drug cost: $14,373 (USD; Tot_Drug_Cst)2023 Drug cost: $12,531 (USD; Tot_Drug_Cst)2024 Drug cost: $12,921 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151447$2,937
2016N/R23$1,154
20172974$3,165
201856158$12,157
201965252$15,577
202070238$20,646
202165203$12,958
202281211$14,373
2023104235$12,531
2024137350$12,921

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg57160$629
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6060$96
67028Injection of drug into eye114140$94
92134Imaging of retina131143$30
J2777Injection, faricimab-svoa, 0.1 mg382,820$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate802,753$2,982
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat533,502$738
Ketorolac TromethamineKetorolac Tromethamine271,120$428
MoxifloxacinMoxifloxacin Hcl25328$324
Dorzolamide HclDorzolamide Hcl231,164$321

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$163Apellis Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Christine Isabel Clavell, MD?

Tedicare shows public-source Medicare data for Christine Isabel Clavell, MD (NPI 1124382056), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christine Isabel Clavell, MD have ACO affiliation data?

Christine Isabel Clavell, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Christine Isabel Clavell, MD?

Christine Isabel Clavell, MD is linked to EYE ASSOCIATES OF NEW MEXICO LTD (billing NPI 1104868520) in the available physician profile data.

Does Christine Isabel Clavell, MD have Open Payments data?

Christine Isabel Clavell, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.